Why has the Lynas share price surged 22% in the last 3 weeks?

It's been a stellar run for the company since the start of FY23.

| More on:
Happy woman miner with her thumb up signalling Wyloo's commitment to back IGO's takeover of Western Areas nickel

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Lynas shares have outperformed in the last three weeks, gaining 22%
  • It follows a string of positive announcements from the company, bolstering investors' interest
  • In the last 12 months, the Lynas share price has clipped a 23% gain

The Lynas Rare Earths Ltd (ASX: LYC) share price has outperformed its benchmarks in the new financial year.

In the last three weeks of trade, investors have bid the share 22% higher.

In broad market moves, the S&P/ASX 300 Metals and Mining Index (ASX: XMM) has risen less than 1% over the past month of trade.

What's up with the Lynas share price?

Lynas shares caught a bid on 13 July and have surged ever since.

It's curious because as commodity markets such as oil and gas cool off, rare earths have followed suit. Their price on global markets is down 13% on the month.

Despite this, investors have piled into Lynas shares since mid-July, with trading volumes shooting higher again yesterday following a company announcement.

The miner advised of a $500 million project to expand capacity at its Western Australia Mt Weld mine and concentration plant.

As The Motley Fool reported, global demand for NdFeB [neodymium] magnets is expected to grow from 130,000 tonnes in 2020 to 265,000 tonnes by 2030.

Lynas' new project is fully funded from cash flow. The company's initial expansion plans have already been scoped, with Lynas looking to produce 12,000 tonnes per annum equivalent of neodymium and praseodymium in 2024.

Prior to this, the company's Q2 FY22 earnings report was a positive catalyst that saw shares head back to longer-term price ranges.

In the report, Lynas grew cash receipts to a record $351 million, also 34% up on the same time last year. This was recognised with sales revenue of roughly $295 million.

In the last 12 months, the Lynas share price has clipped a 23% gain.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Bendigo Bank, NextDC, Nuix, and Vulcan Energy shares are rising today

These shares are ending the week on a high. But why?

Read more »